Bryan Hubbard
September 14 2018

Independent drug trials aren't always quite so independent. Researchers are still not revealing the pay-outs they're getting from drug companies whose drugs they are testing—and in some cases they even have shares in the company. Around a third of researchers are not disclosing their financial conflicts of interest despite the enormous pressure from medical journals for transparency in clinical trials.

Some researchers get speaking fees, others receive 'research grants' and others hold shares in the drug company whose drug they are reviewing, but which they are not revealing in their research that is presented as being independent

Read more: